Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics

D. Ahn; A. Barzi; R. A. Miksad; A. Surinach; F. A. Corvino; A. Valderrama; K. Mamlouk; S. Pulgar; T. Bekaii-Saab

doi:10.1093/annonc/mdy282.118

Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics

D. Ahn, A. Barzi, R. A. Miksad, A. Surinach, F. A. Corvino, A. Valderrama, K. Mamlouk, S. Pulgar, T. Bekaii-Saab

Hematology/Oncology

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	viii251
Journal	Annals of oncology : official journal of the European Society for Medical Oncology
Volume	29
DOIs	https://doi.org/10.1093/annonc/mdy282.118
State	Published - Oct 1 2018

ASJC Scopus subject areas

Hematology
Oncology

Access to Document

10.1093/annonc/mdy282.118

Cite this

Ahn, D., Barzi, A., Miksad, R. A., Surinach, A., Corvino, F. A., Valderrama, A., Mamlouk, K., Pulgar, S., & Bekaii-Saab, T. (2018). Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics. Annals of oncology : official journal of the European Society for Medical Oncology, 29, viii251. https://doi.org/10.1093/annonc/mdy282.118

Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics. / Ahn, D.; Barzi, A.; Miksad, R. A. et al.
In: Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, 01.10.2018, p. viii251.

Research output: Contribution to journal › Article › peer-review

Ahn, D, Barzi, A, Miksad, RA, Surinach, A, Corvino, FA, Valderrama, A, Mamlouk, K, Pulgar, S & Bekaii-Saab, T 2018, 'Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 29, pp. viii251. https://doi.org/10.1093/annonc/mdy282.118

@article{32554075d71c45658fd1c9d1c3a0b48d,

title = "Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics",

author = "D. Ahn and A. Barzi and Miksad, {R. A.} and A. Surinach and Corvino, {F. A.} and A. Valderrama and K. Mamlouk and S. Pulgar and T. Bekaii-Saab",

year = "2018",

month = oct,

day = "1",

doi = "10.1093/annonc/mdy282.118",

language = "English (US)",

volume = "29",

pages = "viii251",

journal = "Annals of oncology : official journal of the European Society for Medical Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics

AU - Ahn, D.

AU - Barzi, A.

AU - Miksad, R. A.

AU - Surinach, A.

AU - Corvino, F. A.

AU - Valderrama, A.

AU - Mamlouk, K.

AU - Pulgar, S.

AU - Bekaii-Saab, T.

PY - 2018/10/1

Y1 - 2018/10/1

UR - http://www.scopus.com/inward/record.url?scp=85081531061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85081531061&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdy282.118

DO - 10.1093/annonc/mdy282.118

M3 - Article

C2 - 32136559

SN - 0923-7534

VL - 29

SP - viii251

JO - Annals of oncology : official journal of the European Society for Medical Oncology

JF - Annals of oncology : official journal of the European Society for Medical Oncology

ER -

Real-world dosing patterns of patients (pts) with metastatic pancreatic cancer (mPC) treated with liposomal irinotecan (nal-IRI) in US oncology clinics

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this